因销售不合格药品案，国药一致全资子公司被行政处罚

Core Viewpoint - Guoyao Holdings Shenzhen Jianmin Co., Ltd. has been administratively punished by the Shenzhen Market Supervision Administration for selling substandard drugs, resulting in the confiscation of illegal gains amounting to 24,115.56 yuan [1][3]. Group 1: Administrative Penalty Details - The penalty was issued due to illegal drug sales [1][3]. - The legal basis for the penalty is the Drug Administration Law Implementation Regulations of the People's Republic of China, specifically Article 75, which states that if a drug business entity or medical institution can prove they were unaware of selling counterfeit or inferior drugs, they may have their illegal gains confiscated but can be exempted from other administrative penalties [1][3]. - The penalty decision was made on September 12, 2025, by the Shenzhen Market Supervision Administration [3]. Group 2: Company Information - Guoyao Holdings Shenzhen Jianmin Co., Ltd. was established on March 2, 1982, and is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (Guoyao Group) [1][3]. - The legal representative of the company is Niu Zhifu [3][4]. - The company is currently active and registered with a capital of 200 million yuan [6].